4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-methyl-2-N-[(3-pyridin-3-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine
C20H20N8O — CID 59757781
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-methyl-2-N-[(3-pyridin-3-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine
4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-methyl-2-N-[(3-pyridin-3-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine (PubChem CID 59757781) has the molecular formula C20H20N8O and a molecular weight of 388.44 g/mol. Its IUPAC name is 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-methyl-2-N-[(3-pyridin-3-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine.
Molecular Properties
| Compound Name | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-methyl-2-N-[(3-pyridin-3-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine |
|---|---|
| PubChem CID | 59757781 |
| Molecular Formula | C20H20N8O |
| Molecular Weight | 388.44 g/mol |
| Exact Mass | 388.18 |
| IUPAC Name | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-methyl-2-N-[(3-pyridin-3-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine |
| SMILES | Cc1cc(Nc2cc(C3CC3)[nH]n2)nc(NCc2cc(-c3cccnc3)no2)n1 |
| InChI | InChI=1S/C20H20N8O/c1-12-7-18(24-19-9-16(26-27-19)13-4-5-13)25-20(23-12)22-11-15-8-17(28-29-15)14-3-2-6-21-10-14/h2-3,6-10,13H,4-5,11H2,1H3,(H3,22,23,24,25,26,27) |
| InChIKey | DXZXQSHJPGLYFB-UHFFFAOYSA-N |
| XLogP | 3.79 |
| TPSA | 117.44 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 388.44 |
| LogP ≤ 5 | 3.79 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59757781 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.